Kossan Rubber Industries Bhd (KSRBF)
USD 0.27
(0.0%)
USD 0.27
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 239.22 Million MYR | -16.67% |
| 2022 | 287.07 Million MYR | -32.3% |
| 2021 | 424.02 Million MYR | -3.62% |
| 2020 | 439.94 Million MYR | 36.83% |
| 2019 | 321.52 Million MYR | 29.12% |
| 2018 | 249 Million MYR | 16.93% |
| 2017 | 212.95 Million MYR | 1.08% |
| 2016 | 210.67 Million MYR | 2.47% |
| 2015 | 205.58 Million MYR | 6.23% |
| 2014 | 193.53 Million MYR | 30.08% |
| 2013 | 148.78 Million MYR | -0.13% |
| 2012 | 148.98 Million MYR | -9.04% |
| 2011 | 163.77 Million MYR | 32.45% |
| 2010 | 123.65 Million MYR | 12.5% |
| 2009 | 109.91 Million MYR | -1.86% |
| 2008 | 112 Million MYR | 29.08% |
| 2007 | 86.77 Million MYR | 36.35% |
| 2006 | 63.63 Million MYR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 260.14 Million MYR | 18.22% |
| 2024 Q1 | 220.04 Million MYR | -8.02% |
| 2023 Q2 | 246.78 Million MYR | -3.24% |
| 2023 Q1 | 255.06 Million MYR | -11.15% |
| 2023 Q4 | 239.22 Million MYR | 0.27% |
| 2023 Q3 | 238.58 Million MYR | -3.32% |
| 2023 FY | 239.22 Million MYR | -16.67% |
| 2022 Q4 | 287.07 Million MYR | -11.58% |
| 2022 Q2 | 393.13 Million MYR | 0.55% |
| 2022 Q1 | 390.99 Million MYR | -7.79% |
| 2022 FY | 287.07 Million MYR | -32.3% |
| 2022 Q3 | 324.66 Million MYR | -17.42% |
| 2021 Q3 | 407.66 Million MYR | 9.0% |
| 2021 Q4 | 424.02 Million MYR | 4.01% |
| 2021 Q1 | 400.57 Million MYR | -8.95% |
| 2021 FY | 424.02 Million MYR | -3.62% |
| 2021 Q2 | 374 Million MYR | -6.63% |
| 2020 Q3 | 326.85 Million MYR | -2.97% |
| 2020 Q1 | 311.23 Million MYR | -3.2% |
| 2020 Q2 | 336.84 Million MYR | 8.23% |
| 2020 Q4 | 439.94 Million MYR | 34.6% |
| 2020 FY | 439.94 Million MYR | 36.83% |
| 2019 FY | 321.52 Million MYR | 29.12% |
| 2019 Q4 | 321.52 Million MYR | 11.68% |
| 2019 Q1 | 255.1 Million MYR | 2.45% |
| 2019 Q2 | 266.15 Million MYR | 4.33% |
| 2019 Q3 | 287.88 Million MYR | 8.16% |
| 2018 Q4 | 249 Million MYR | 0.08% |
| 2018 Q3 | 248.8 Million MYR | 0.46% |
| 2018 Q1 | 221.97 Million MYR | 4.24% |
| 2018 FY | 249 Million MYR | 16.93% |
| 2018 Q2 | 247.66 Million MYR | 11.57% |
| 2017 Q1 | 221.57 Million MYR | 5.18% |
| 2017 FY | 212.95 Million MYR | 1.08% |
| 2017 Q4 | 212.95 Million MYR | 6.07% |
| 2017 Q3 | 200.75 Million MYR | -4.98% |
| 2017 Q2 | 211.27 Million MYR | -4.65% |
| 2016 Q1 | 208.92 Million MYR | 1.62% |
| 2016 FY | 210.67 Million MYR | 2.47% |
| 2016 Q2 | 210.2 Million MYR | 0.61% |
| 2016 Q3 | 210.98 Million MYR | 0.37% |
| 2016 Q4 | 210.67 Million MYR | -0.15% |
| 2015 Q2 | 213.93 Million MYR | 9.26% |
| 2015 Q3 | 206.03 Million MYR | -3.69% |
| 2015 Q4 | 205.58 Million MYR | -0.22% |
| 2015 FY | 205.58 Million MYR | 6.23% |
| 2015 Q1 | 195.79 Million MYR | 1.17% |
| 2014 Q4 | 193.53 Million MYR | 5.13% |
| 2014 Q1 | 153.2 Million MYR | 2.97% |
| 2014 Q3 | 184.09 Million MYR | 10.68% |
| 2014 Q2 | 166.32 Million MYR | 8.56% |
| 2014 FY | 193.53 Million MYR | 30.08% |
| 2013 Q1 | 146.05 Million MYR | -1.96% |
| 2013 FY | 148.78 Million MYR | -0.13% |
| 2013 Q4 | 148.78 Million MYR | 2.84% |
| 2013 Q3 | 144.67 Million MYR | -2.82% |
| 2013 Q2 | 148.86 Million MYR | 1.92% |
| 2012 Q3 | 158.46 Million MYR | -5.47% |
| 2012 FY | 148.98 Million MYR | -9.04% |
| 2012 Q2 | 167.63 Million MYR | 2.63% |
| 2012 Q4 | 148.98 Million MYR | -5.98% |
| 2012 Q1 | 163.34 Million MYR | 0.0% |
| 2011 FY | 163.77 Million MYR | 32.45% |
| 2010 FY | 123.65 Million MYR | 12.5% |
| 2009 FY | 109.91 Million MYR | -1.86% |
| 2008 FY | 112 Million MYR | 29.08% |
| 2007 FY | 86.77 Million MYR | 36.35% |
| 2006 FY | 63.63 Million MYR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| American Medical Technologies Inc. | 133.82 Thousand USD | -178656.473% |
| Ansell Limited | 457.04 Million USD | 47.657% |
| Ansell Limited | 457.9 Million USD | 47.755% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 43.33 Million USD | -452.035% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 27.89 Thousand USD | -857655.468% |
| Psykey, Inc. | 49.94 Thousand USD | -478930.837% |
| ConvaTec Group Plc | 395.54 Million USD | 39.519% |
| ConvaTec Group Plc | 396.1 Million USD | 39.604% |
| Encision Inc. | 1.4 Million USD | -16959.225% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | -9294.00 USD | 2574104.734% |
| LifePoint, Inc. | 2.3 Million USD | -10259.137% |
| Medite Cancer Diagnostics, Inc. | 2.4 Million USD | -9855.389% |
| Paradigm Medical Industries, Inc. | 441 Thousand USD | -54146.712% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 91.88 Thousand USD | -260264.38% |
| Reflect Scientific, Inc. | 972.29 Thousand USD | -24504.517% |
| SmileDirectClub, Inc. | 49.87 Million USD | -379.665% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 351.74 Million USD | 31.989% |
| SheerVision, Inc. | 339.66 Thousand USD | -70330.986% |
| United Health Products, Inc. | 33.59 Thousand USD | -711930.478% |
| Vasamed, Inc. | 449.02 Thousand USD | -53176.856% |
| Wearable Health Solutions, Inc. | 8555.00 USD | -2796253.01% |
| Yubo International Biotech Limited | 322.17 Thousand USD | -74154.515% |